Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Ingvild Odsbu

52 publications found

Original articles

Amundsen EJ, Odsbu I, Skurtveit SO, Gjersing L (2024)
Patterns of filled prescriptions and the association with risk of drug-induced death. A population-based nested case-control register study
Pharmacoepidemiol Drug Saf, 33 (2), e5763
DOI 10.1002/pds.5763, PubMed 38357780

Odsbu I, Hjellvik V, Handal M, Hamina A, Clausen T, Lid TG, Borchgrevink PC, Skurtveit S (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0414, PubMed 38349107

Bachmann CJ, Scholle O, Bliddal M, dosReis S, Odsbu I, Skurtveit S, Wesselhoeft R, Vivirito A, Zhang C, Scott S (2024)
Recognition and management of children and adolescents with conduct disorder: a real-world data study from four western countries
Child Adolesc Psychiatry Ment Health, 18 (1), 18
DOI 10.1186/s13034-024-00710-6, PubMed 38281951

Cohen JM, Alvestad S, Suarez EA, Schaffer A, Selmer RM, Havard A, Bateman BT, Cesta CE, Zoega H, Odsbu I, Huybrechts KF, Kjerpeseth LJ, Straub L, Leinonen MK, Bjørk MH, Nørgaard M, Gissler M, Ulrichsen SP, Hernandez-Diaz S, Tomson T, Furu K (2023)
Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy
Neurology, 102 (2), e207996
DOI 10.1212/WNL.0000000000207996, PubMed 38165339

Nakitanda AO, Odsbu I, Pasternak B, Karlsson P, Pazzagli L (2023)
Antibiotic use during pregnancy in Sweden: A nationwide utilization study covering 2007-2019
Acta Obstet Gynecol Scand, 103 (3), 531-539
DOI 10.1111/aogs.14741, PubMed 38108616

Hamina A, Odsbu I, Hjellvik V, Lid TG, Clausen T, Skurtveit S (2023)
Fatal drug overdoses in individuals treated pharmacologically for chronic pain: a nationwide register-based study
Br J Anaesth, 132 (1), 86-95
DOI 10.1016/j.bja.2023.10.016, PubMed 37953201

Eide D, McDonald R, Hamina A, Clausen T, Odsbu I, Skurtveit S (2023)
Prescription high-risk polysubstance use among opioid maintenance treatment patients
Int J Drug Policy, 104196 (in press)
DOI 10.1016/j.drugpo.2023.104196, PubMed 37741700

Rolová G, Eide D, Gabrhelík R, Odsbu I, Clausen T, Skurtveit S (2023)
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
Subst Abuse Treat Prev Policy, 18 (1), 47
DOI 10.1186/s13011-023-00557-8, PubMed 37507709

Nestvold HH, Skurtveit SS, Hamina A, Hjellvik V, Odsbu I (2023)
Socioeconomic risk factors for long-term opioid use: A national registry-linkage study
Eur J Pain, 28 (1), 95-104
DOI 10.1002/ejp.2163, PubMed 37501355

Odsbu I, Handal M, Hjellvik V, Hernandez-Diaz S, Kieler H, Nørgaard M, Skurtveit S, Esen BÖ, Mahic M (2023)
Prenatal opioid exposure and risk of asthma in childhood: a population-based study from Denmark, Norway, and Sweden
Front Pharmacol, 14, 1056192
DOI 10.3389/fphar.2023.1056192, PubMed 37214456

Gjerde LC, Skurtveit S, Handal M, Nesvåg R, Clausen T, Lid TG, Hamina A, Borchgrevink PC, Odsbu I (2023)
Mental disorder prevalence in chronic pain patients using opioid versus non-opioid analgesics: A registry-linkage study
Eur J Pain, 27 (7), 884-895
DOI 10.1002/ejp.2121, PubMed 37133299

Dudukina E, Szépligeti SK, Karlsson P, Asomaning K, Daltveit AK, Hakkarainen K, Hoti F, Kieler H, Lunde A, Odsbu I, Rantanen M, Reutfors J, Saarelainen L, Ehrenstein V, Toft G (2023)
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries
Drug Saf, 46 (7), 661-675
DOI 10.1007/s40264-023-01307-2, PubMed 37099261

Njotto LL, Simin J, Fornes R, Odsbu I, Mussche I, Callens S, Engstrand L, Bruyndonckx R, Brusselaers N (2023)
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study
Drug Saf, 46 (5), 467-478
DOI 10.1007/s40264-023-01297-1, PubMed 37087706

Pasman JA, Meijsen JJ, Haram M, Kowalec K, Harder A, Xiong Y, Nguyen TD, Jangmo A, Shorter JR, Bergstedt J, Das U, Zetterberg R, Tate A, Lichtenstein P, Larsson H, Odsbu I, Werge T, Reichborn-Kjennerud T, Andreassen OA, Sullivan PF, Buil A, Tesli M, Lu Y (2023)
Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers
Lancet Reg Health Eur, 29, 100621
DOI 10.1016/j.lanepe.2023.100621, PubMed 37265784

Nakitanda AO, Kieler H, Odsbu I, Rhedin S, Almqvist C, Pasternak B, Pazzagli L (2023)
In-utero antibiotic exposure and subsequent infections in infancy: a register-based cohort study with sibling analysis
Am J Obstet Gynecol MFM, 5 (4), 100860
DOI 10.1016/j.ajogmf.2023.100860, PubMed 36626967

Eide D, Skurtveit S, Clausen T, Hesse M, Mravčík V, Nechanská B, Rolova G, Thylstrup B, Tjagvad C, Seid AK, Odsbu I, Gabrhelík R (2023)
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study
Eur Addict Res, 29 (4), 272-284
DOI 10.1159/000530822, PubMed 37385232

Cohen JM, Alvestad S, Cesta CE, Bjørk MH, Leinonen MK, Nørgaard M, Einarsdóttir K, Engeland A, Gissler M, Karlstad Ø, Klungsøyr K, Odsbu I, Reutfors J, Selmer RM, Tomson T, Ulrichsen SP, Zoega H, Furu K (2022)
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations
Ann Neurol, 93 (3), 551-562
DOI 10.1002/ana.26561, PubMed 36433783

Hamina A, Odsbu I, Borchgrevink PC, Chen LC, Clausen T, Espnes KA, Gjesdal K, Handal M, Hartikainen S, Hjellvik V, Holter MTS, Høibø T, Kurita GP, Langaas HC, Lid TG, Nøst TH, Sjøgren P, Skurtveit S, POINT study group (2022)
Cohort Description: Preventing an Opioid Epidemic in Norway - Focusing on Treatment of Chronic Pain (POINT) - A National Registry-Based Study
Clin Epidemiol, 14, 1477-1486
DOI 10.2147/CLEP.S382136, PubMed 36523790

Pazzagli L, Segovia Chacón S, Karampelias C, Cohen JM, Bröms G, Kieler H, Odsbu I, Selmer R, Andersson O, Cesta CE (2022)
Association between folic acid use during pregnancy and gestational diabetes mellitus: Two population-based Nordic cohort studies
PLoS One, 17 (8), e0272046
DOI 10.1371/journal.pone.0272046, PubMed 35951607

Nakitanda AO, Karlsson P, Löfling L, Cesta CE, Odsbu I (2022)
Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns
BMC Infect Dis, 22 (1), 492
DOI 10.1186/s12879-022-07405-3, PubMed 35610597

Hamina A, Muller AE, Clausen T, Skurtveit S, Hesse M, Tjagvad C, Thylstrup B, Odsbu I, Zoega H, Jónsdóttir HL, Taipale H (2022)
Prescription opioids among older adults: ten years of data across five countries
BMC Geriatr, 22 (1), 429
DOI 10.1186/s12877-022-03125-0, PubMed 35578167

Odsbu I, Handal M, Hjellvik V, Borchgrevink PC, Clausen T, Nesvåg R, Skurtveit S (2022)
[Long-term use of opioids and concomitant use of other habit-forming drugs]
Tidsskr Nor Laegeforen, 142 (3)
DOI 10.4045/tidsskr.21.0659, PubMed 35170913

Hamina A, Hjellvik V, Handal M, Odsbu I, Clausen T, Skurtveit S (2022)
Describing long-term opioid use utilizing Nordic prescription registers-A Norwegian example
Basic Clin Pharmacol Toxicol, 130 (4), 481-491
DOI 10.1111/bcpt.13706, PubMed 35037407

Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E et al. (2021)
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe
Pharmacoepidemiol Drug Saf, 30 (10), 1447-1457
DOI 10.1002/pds.5319, PubMed 34181291

Hoffman V, Hallas J, Linder M, Margulis AV, Suehs BT, Arana A, Phiri K, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S, Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD, mirabegron PMR-PASS study group (2021)
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Drug Saf, 44 (8), 899-915
DOI 10.1007/s40264-021-01095-7, PubMed 34236595

Phiri K, Hallas J, Linder M, Margulis A, Suehs B, Arana A, Bahmanyar S, Hoffman V, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S, Kristiansen NS, Appenteng K, de Vogel S, Seeger J (2021)
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder
Curr Med Res Opin, 37 (5), 867-877
DOI 10.1080/03007995.2021.1891035, PubMed 33591859

Srinivas C, Odsbu I, Linder M (2020)
Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab
Pharmacoepidemiol Drug Saf, 29 (12), 1562-1569
DOI 10.1002/pds.5132, PubMed 32975344

Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Økland JM, Leiva RAM, Vickerman P, Johansson KA, Fadnes LT (2020)
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
BMJ Open, 10 (8), e036355
DOI 10.1136/bmjopen-2019-036355, PubMed 32847908

Mahic M, Hernandez-Diaz S, Wood M, Kieler H, Odsbu I, Nørgaard M, Öztürk B, Bateman BT, Hjellvik V, Skurtveit S, Handal M (2020)
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study
Pharmacoepidemiol Drug Saf, 29 (12), 1596-1604
DOI 10.1002/pds.5088, PubMed 32767610

Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Reutfors J, Halmøy A, Johansson KA, Fadnes LT (2020)
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
BMJ Open, 10 (8), e036860
DOI 10.1136/bmjopen-2020-036860, PubMed 32771988

Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Lim AG, Johansson KA, Fadnes LT (2020)
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
Subst Abuse Treat Prev Policy, 15 (1), 44
DOI 10.1186/s13011-020-00286-2, PubMed 32605625

Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Halmøy A, Johansson KA, Fadnes LT (2020)
Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
BMC Psychiatry, 20 (1), 119
DOI 10.1186/s12888-020-02526-y, PubMed 32164615

Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I (2019)
Antidiabetic medication use during pregnancy: an international utilization study
BMJ Open Diabetes Res Care, 7 (1), e000759
DOI 10.1136/bmjdrc-2019-000759, PubMed 31798900

Gilsenan A, Fortuny J, Cainzos-Achirica M, Cantero OF, Flynn RWV, Garcia-Rodriguez L, Harding A, Kollhorst B, Karlsson P, Linnér L, MacDonald TM, Odsbu I, Plana E, Ruigómez A, Schink T, Ziemiecki R, Andrews EB (2019)
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
Drug Saf, 42 (10), 1179-1190
DOI 10.1007/s40264-019-00835-0, PubMed 31134512

Muller AE, Clausen T, Sjøgren P, Odsbu I, Skurtveit S (2019)
Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017
Scand J Pain, 19 (2), 345-353
DOI 10.1515/sjpain-2018-0307, PubMed 30677000

Steens A, Winje BA, White RA, Odsbu I, Brantsæter AB, Vestrheim DF (2019)
Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study
Clin Infect Dis, 68 (8), 1367-1373
DOI 10.1093/cid/ciy714, PubMed 30957160

Yao Y, Enkhtsetseg S, Odsbu I, Fan L, Morigen M (2018)
Mutations of DnaA-boxes in the oriR region increase replication frequency of the MiniR1-1 plasmid
BMC Microbiol, 18 (1), 27
DOI 10.1186/s12866-018-1162-3, PubMed 29614952

Odsbu I, Khedkar S, Khedkar U, Nerkar SS, Tamhankar AJ, Stålsby Lundborg C (2018)
High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates
Int J Environ Res Public Health, 15 (1)
DOI 10.3390/ijerph15010153, PubMed 29351187

Odsbu I, Khedkar S, Lind F, Khedkar U, Nerkar SS, Orsini N, Tamhankar AJ, Stålsby Lundborg C (2018)
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014
Int J Environ Res Public Health, 15 (1)
DOI 10.3390/ijerph15010155, PubMed 29351236

Odsbu I, Selmer R, Stålsby Lundborg C, Blix HS (2017)
Increased prescribing of systemic tetracyclines and isotretinoin for treatment of acne
J Antimicrob Chemother, 72 (5), 1510-1515
DOI 10.1093/jac/dkw586, PubMed 28158436

Yao Y, Fan L, Shi Y, Odsbu I, Morigen (2016)
A Spatial Control for Correct Timing of Gene Expression during the Escherichia coli Cell Cycle
Genes (Basel), 8 (1)
DOI 10.3390/genes8010001, PubMed 28025549

Odsbu I, Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2014)
Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age
Eur J Clin Pharmacol, 71 (3), 283-91
DOI 10.1007/s00228-014-1797-4, PubMed 25547568

Odsbu I, Skarstad K (2014)
DNA compaction in the early part of the SOS response is dependent on RecN and RecA
Microbiology (Reading), 160 (Pt 5), 872-882
DOI 10.1099/mic.0.075051-0, PubMed 24615185

Weel-Sneve R, Kristiansen KI, Odsbu I, Dalhus B, Booth J, Rognes T, Skarstad K, Bjørås M (2013)
Single transmembrane peptide DinQ modulates membrane-dependent activities
PLoS Genet, 9 (2), e1003260
DOI 10.1371/journal.pgen.1003260, PubMed 23408903

Johnsen E, Wilson SR, Odsbu I, Krapp A, Malerod H, Skarstad K, Lundanes E (2011)
Hydrophilic interaction chromatography of nucleoside triphosphates with temperature as a separation parameter
J Chromatogr A, 1218 (35), 5981-6
DOI 10.1016/j.chroma.2011.01.066, PubMed 21315360

Odsbu I, Morigen, Skarstad K (2009)
A reduction in ribonucleotide reductase activity slows down the chromosome replication fork but does not change its localization
PLoS One, 4 (10), e7617
DOI 10.1371/journal.pone.0007617, PubMed 19898675

Morigen, Odsbu I, Skarstad K (2009)
Growth rate dependent numbers of SeqA structures organize the multiple replication forks in rapidly growing Escherichia coli
Genes Cells, 14 (5), 643-57
DOI 10.1111/j.1365-2443.2009.01298.x, PubMed 19371375

Odsbu I, Klungsøyr HK, Fossum S, Skarstad K (2005)
Specific N-terminal interactions of the Escherichia coli SeqA protein are required to form multimers that restrain negative supercoils and form foci
Genes Cells, 10 (11), 1039-49
DOI 10.1111/j.1365-2443.2005.00898.x, PubMed 16236133